SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aventis Pharma’s Q4 net tumbles 66%

24 Feb 2012 Evaluate

Aventis Pharma’s net profit declined 65.58% to Rs 36.10 crore for the fourth quarter ended December 31, due to the acquisition of nutraceutical formulations business of Universal Medicare. The company had posted net profit of Rs 104.90 crore in the October-December period last year.

The company’s net sales rose to Rs 337.90 crore during the fourth quarter, as against Rs 286.50 crore in the same period previous year.

The profit for the quarter ended December 31, 2011 has been impacted due to the costs relating to the above acquisition and lower interest income as a result of the investment.

For the entire 2011, the company posted net profit of Rs 191.20 crore, as compared to Rs 230.70 crore in 2010. Net sales of the company for the year were Rs 1,229.70 crore, as against Rs 1,085 crore in 2010.

Sanofi India Share Price

3562.15 -16.40 (-0.46%)
21-Apr-2026 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.95
Dr. Reddys Lab 1242.75
Cipla 1230.00
Zydus Lifesciences 935.00
Lupin 2337.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×